Covalent warheads targeting cysteine residue: the promising approach in drug development
Although, if you stop your treatment within six months for an unprovoked blood clot, chances of recurrence are near 20 to 30 percent
Drug delivery methods based on nanomaterials are attractive options in the search for therapeutic advantages because of their distinctive properties
A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes
PMID: 19570099
KEY INGREDIENTS: Purified Water, Ethyl ascorbic Acid, Glycerine, Niacinamide, Sodium Carbomer, Sodium Hyaluronate, 2- phenoxyethanol, Sodium Gluconate, Xanthan Gum, Allantoin, Butylene Glycol, Ferulic Acid, Kakadu plum Extract, Emblica officinalis Extract, Acai berry Extract, Fragrance.